Additional sedative drugs to light sedation with dexmedetomidine is risk for delirium by unknown
POSTER PRESENTATION Open Access
Additional sedative drugs to light sedation with
dexmedetomidine is risk for delirium
M Sakuraya*, A Hirata, K Yoshida, N Kawamura, T Tsutsui
From ESICM LIVES 2015
Berlin, Germany. 3-7 October 2015
Introduction
Light sedation is preferred for critical ill patients. We
often use dexmedetomidine for light sedation, but some-
times additional sedative drugs(such as midazolam and
propofol) is needed. Benzodiazepine is risk for delirium,
but it is unclear benzodiazepine use combined with dex-
medetomidine is risk for delirium.
Methods
This prospective observational study was conducted in
open ICU, urban hospital(Hiroshima, Japan) between Feb-
ruary 2013 and March 2015. Adult patients intubated
within 24 hours from ICU admission and underwent light
sedation with dexmedetomidine was eligible. Exclusion
criteria were: age < 18, stroke, cardiopulmonary arrest,
neurosurgery, seizure, traumatic brain injury. We com-
pared alternative sedative dug use with no additional drug.
Primary outcome is delirium incidence.
Results
268 patients were eligible and 254 patients were analyzed.
Median age (Q1-Q3) was 74 (66-81) years, 162 male
(64%), median APACHE II score was 19 (15-23). 89
patients were administrated additional sedative drugs
(midazolam 14, propofol 80). Delirium was observed
more frequently compared with dexmedetomidine alone,
41 (46%) vs. 51 (31%), p = 0.02. Additional sedative drugs
were associated with prolong ICU stay (5 (3-8) days vs. 3
(2-4.5) days, p < 0.001) and decreased ventilator free days
(25 (21-26) days vs. 26 (26-27) days, p < 0.001).
Conclusions
Additional sedative drugs to light sedation with dexme-
detomidine might be risk for delirium.
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